Literature DB >> 15028815

Chemoembolization of liver metastasis from breast carcinoma.

Marie-France Giroux1, Richard A Baum, Michael C Soulen.   

Abstract

Chemoembolization was performed in eight patients with liver metastasis from breast carcinoma. Five of eight patients had some radiographic regression of the liver tumors, one had stable liver disease, and two had disease progression. Two of four patients with pain showed clinical improvement of their symptoms. Only one patient with radiographic response or disease stabilization subsequently had intrahepatic progression (at 3 months). Five patients developed other metastasis, particularly brain metastasis, at a mean of 4.6 months after first chemoembolization (range, 2-12 months). All patients died within 13 months of treatment, with a mean survival of 49 months from primary diagnosis, 20 months from liver metastasis diagnosis, and 6 months from first chemoembolization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028815     DOI: 10.1097/01.rvi.0000116190.44877.04

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  17 in total

Review 1.  Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Curr Treat Options Oncol       Date:  2012-09

Review 2.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 3.  Rationale of transcatheter intra-arterial therapies of hepatic cancers.

Authors:  Ryan M Hickey; Robert J Lewandowski; Riad Salem
Journal:  Hepat Oncol       Date:  2014-09-09

Review 4.  Improvement of survival and prospect of cure in patients with metastatic breast cancer.

Authors:  Yee Chung Cheng; Naoto T Ueno
Journal:  Breast Cancer       Date:  2011-05-13       Impact factor: 4.239

Review 5.  Transcatheter intraarterial therapies: rationale and overview.

Authors:  Robert J Lewandowski; Jean-Francois Geschwind; Eleni Liapi; Riad Salem
Journal:  Radiology       Date:  2011-06       Impact factor: 11.105

Review 6.  Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.

Authors:  Susan Shamimi-Noori; Carin F Gonsalves; Colette M Shaw
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

7.  Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.

Authors:  Avo Artinyan; Rebecca Nelson; Perry Soriano; Vincent Chung; Janet Retseck; Jonathon Reynolds; Howard Marx; Joseph Kim; Lawrence Wagman
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

8.  Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.

Authors:  Thomas J Vogl; Nagy N N Naguib; Nour-Eldin A Nour-Eldin; Katrin Eichler; Stefan Zangos; Tatjana Gruber-Rouh
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

9.  Techniques of interventional tumor therapy.

Authors:  Andreas H Mahnken; Philipp Bruners; Rolf W Günther
Journal:  Dtsch Arztebl Int       Date:  2008-09-19       Impact factor: 5.594

Review 10.  Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations.

Authors:  Peter Gunvén
Journal:  Med Oncol       Date:  2007-08-03       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.